Medical News

RSS

IMS supports new guidance on glucocorticoid use

The International Osteoporosis Foundation, along with the European Society for Calcified Tissue, launched new guidance on glucocorticoid use at the European Congress on Osteoporosis and Osteoarthritis (which took place in Bordeaux from March 21 - 24, 2012). Given the special relevance to postmenopausal women, the International Menopause Society (IMS) is supporting the publication of the guidance.

31 Mar 2012

PLC receives Brazilian government approval to market RenalGuard System

PLC Systems Inc., a company focused on innovative medical device technologies, today announced that it had received approval from the Brazilian government to market its innovative RenalGuard System in that country.

31 Mar 2012

Revitalized Stop Bullying website

Building on the momentum the Obama administration started more than a year ago to stop bullying in schools and communities, Health and Human Services (HHS) Secretary Kathleen Sebelius and Education Secretary Arne Duncan today unveiled a revitalized Stop Bullying website- www.stopbullying.gov - to encourage children, parents, educators, and communities to take action to stop and prevent bullying.

31 Mar 2012

Birner Dental Management Services 2011 revenue decreases 1.4% to $63.1M

Birner Dental Management Services, Inc., operators of PERFECT TEETH dental practices and Vantage Dental Implant Center, announced results for the year and quarter ended December 31, 2011.

31 Mar 2012

ImmunoGen commences IMGN901 Phase II evaluation for SCLC

ImmunoGen, Inc. today announced that it has initiated Phase II testing of its IMGN901 product candidate for first-line treatment of SCLC.

31 Mar 2012

FDA approves Roche's cobas p 630 pre-analytical instrument

Roche announced today the FDA approval of a new pre-analytical instrument that provides an integrated primary tube handling solution for its widely adopted automated molecular testing platform.

31 Mar 2012

Top-line results from Shire's SPD476 phase 3 trial on diverticulitis

Shire plc, the global specialty biopharmaceutical company, today announced top-line results of the PREVENT2 trial, a phase 3 investigational study of once-daily SPD476, MMX mesalamine in patients with a history of diverticulitis.

31 Mar 2012

Prenatal, early childhood mechanisms are potential intervention targets for asthma prevention

Children who develop asthma by age seven have deficits in lung function and increased bronchial responsiveness as neonates, a new study from researchers in Denmark suggests.

31 Mar 2012

SPIN fourth quarter net revenue increases 53% to $5,212,165

Spine Pain Management, Inc., through its Chief Executive Officer, William F. Donovan, M.D., is pleased to report financial results for the year ended December 31, 2011.

31 Mar 2012

Bionovo 2011 total revenues decrease to $0.3 million

Bionovo, Inc., a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, today announced financial results for the year ended December 31, 2011.

31 Mar 2012

Study shows how eating fast food is linked to increased risk of depression

A new study along the same lines as its predecessors shows how eating fast food is linked to a greater risk of suffering from depression. This study has been published in the Public Health Nutrition journal

31 Mar 2012

AlphaCore Pharma commences ACP-501 Phase 1 study in coronary arterial disease

AlphaCore Pharma, a biopharmaceutical company developing ACP-501 (rhLCAT) for the treatment of high risk atherosclerosis and serious lipid metabolism disorders, today announced the initiation of a Phase 1 study of ACP-501 in patients with stable coronary arterial disease.

31 Mar 2012

HIT raises $2.75 M USD in Series A funding

HIT Application Solutions, a leading healthcare technology development company, announced today the company has raised $2.75 M USD in its Series A funding effort.

31 Mar 2012

Cancer patients with CDI may benefit from DIFICLIR drug

New data presented at the 22nd European Congress of Clinical Microbiology and Infectious Diseases (ECCMID) demonstrate that in cancer patients with CDI, DIFICLIR(fidaxomicin) may offer significant benefits in terms of clinical cure, recurrence and sustained clinical cure.

31 Mar 2012

Intronix launches Myoguide Needle EMG Guided Injection System

Great things come in small packages, or at least that's what leading neurologists, physiatrists and clinicians are now discovering with the revolutionary Myoguide Needle EMG Guided Injection System. The breakthrough technology, which has just received 510(k) clearance from the United States Food and Drug Administration, gives practitioners a superior way to deliver targeted injections for musculoskeletal pain, spasticity, fibromyalgia, and even cosmetics.

31 Mar 2012

CIC total revenue for fiscal 2011 increases 82% to $1,546,000

Communication Intelligence Corporation, a leading supplier of electronic signature solutions and the recognized leader in biometric signature verification, today reported total revenue of $1,546,000 for the year ended December 31, 2011, an increase of $695,000 or 82%, compared to total revenue of $851,000 in the prior year.

31 Mar 2012